These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7497523)

  • 1. Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy.
    Ramadan MA; Gabr NS; Bacha P; Günzler V; Phillips SM
    Cell Immunol; 1995 Dec; 166(2):217-26. PubMed ID: 7497523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
    Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
    Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies.
    Nichols J; Foss F; Kuzel TM; LeMaistre CF; Platanias L; Ratain MJ; Rook A; Saleh M; Schwartz G
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S34-6. PubMed ID: 9166099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.
    Mathew RC; Cook GA; Blum AM; Metwali A; Felman R; Weinstock JV
    J Immunol; 1992 Jun; 148(11):3572-7. PubMed ID: 1588046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice.
    Layland LE; Wagner H; da Costa CU
    Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of regulatory (interferon-alpha/beta) and accessory (LAF/IL 1) monokine activities from liver granuloma macrophages of Schistosoma mansoni-infected mice.
    Elliott DE; Righthand VF; Boros DL
    J Immunol; 1987 Apr; 138(8):2653-62. PubMed ID: 3104471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Ward JM; Cheever AW; Paul WE; Sher A
    J Immunol; 1999 Jul; 163(1):337-42. PubMed ID: 10384133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IL-2-toxin, DAB389IL-2, inhibits delayed-type hypersensitivity but enhances IgE antibody production.
    Pullerits T; Lundin S; Dahlgren U; Telemo E; Hanson LA; Lötvall J
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):843-9. PubMed ID: 10329818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal administration of Schistosoma mansoni egg antigens-cholera toxin B subunit conjugate to infected mice reduces immunopathology and mortality.
    Sun JB; Li BL; Lakew M; Grzych JM; Capron A; Czerkinsky C; Holmgren J
    Adv Exp Med Biol; 2001; 495():305-9. PubMed ID: 11774583
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice.
    Singh KP; Gerard HC; Hudson AP; Reddy TR; Boros DL
    Immunology; 2005 Mar; 114(3):410-7. PubMed ID: 15720442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
    Yamashita T; Boros DL
    J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of granulomatous inflammation in murine schistosomiasis. V. Antigen-induced T cell-derived suppressor factors down-regulate proliferation and IL-2, but not IL-4, production by CD4+ effector T cells.
    Fidel PL; Boros DL
    J Immunol; 1991 Mar; 146(6):1941-8. PubMed ID: 1672335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes.
    Bousvaros A; Stevens AC; Strom TB; Murphy J; Lamont JT
    Dig Dis Sci; 1997 Jul; 42(7):1542-8. PubMed ID: 9246061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
    Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
    J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni.
    Sadler CH; Rutitzky LI; Stadecker MJ; Wilson RA
    Eur J Immunol; 2003 Apr; 33(4):880-8. PubMed ID: 12672053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 contributes to the IL-5 response in granulomas from mice infected with Schistosoma mansoni.
    Metwali A; Elliott D; Mathew R; Blum A; Weinstock JV
    J Immunol; 1993 Jan; 150(2):536-42. PubMed ID: 8419486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis.
    Flores-Villanueva PO; Zheng XX; Strom TB; Stadecker MJ
    J Immunol; 1996 May; 156(9):3315-20. PubMed ID: 8617955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAB
    Bhopale MK; Hilliard B; Constantinescu CS; Phillips SM; Rostami A
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):318-329. PubMed ID: 28929835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.